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Abstract
Plasmin has been proposed to be an important mediator during inflammation/infection. In this study, by using mice lacking
genes for plasminogen, tissue-type plasminogen activator (tPA), and urokinase-type PA (uPA), we have investigated the
functional roles of active plasmin in infection and sepsis. Two models were used: an infection model by intravenous
injection of 1610
7 CFU of S. aureus, and a sepsis model by intravenous injection of 1.6610
8 CFU of S. aureus. We found that
in the infection model, wild-type (WT) mice showed significantly higher survival rates than plasminogen-deficient (plg
-/-)
mice. However, in the sepsis model, plg
-/- or tPA
-/-/uPA
-/- mice showed the highest survival rate whereas WT and
tPA
+/-/uPA
+/- mice showed the lowest survival rate, and plg
+/-, tPA
-/-, and uPA
-/- mice had an intermediate survival rate.
These results indicate that the levels of active plasmin are critical in determining the survival rate in the sepsis, partly
through high levels of inflammatory cytokines and enhanced STAT3 activation. We conclude that plasmin is beneficial in
infection but promotes the production of inflammatory cytokines in sepsis that may cause tissue destruction, diminished
neutrophil function, and an impaired capacity to kill bacteria which eventually causes death of these mice.
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Introduction
Sepsis is the culmination of complex interactions between the
infecting microorganism and the host immune, inflammatory,
coagulation and anti-coagulation responses [1]. Sepsis caused by
infections with bacteria such as Staphylococcus aureus is a life-
threatening condition that may lead to septic shock, resulting in
multiple organ failure and death [2]. It is well known that disorders
of coagulation and fibrinolysis play a major role in the development
of organ dysfunction during sepsis [3]. Plasmin, a potent serine
protease in fibrinolysis and the key component of the plasminogen
activator (PA) system, is generated by conversion from its precursor,
plasminogen, by either of two physiological PAs, tissue-type PA
(tPA) and urokinase-type PA (uPA) [4]. Besides fibrinolysis, plasmin
also degrades a large range of extracellular matrix substrates and
activates pre-matrix metalloproteinases [5]. Plasmin has therefore
been suggested to be an important upstream regulator of
extracellular matrix remodeling in many tissue degradation-related
innate immune processes such as cell migration, tissue remodeling,
inflammation, and complement activation [6–8].
In addition to its roles in extracellular proteolysis, the PA system
is also involved in generation of pro-inflammatory responses in the
extracellular environment. Studies using plasminogen-deficient
(plg
-/-) mice have provided evidence supporting a role of the PA
system in mediating the migration of inflammatory cells towards
inflammatory sites [9]. In vitro studies have also indicated that
plasmin cleaves components of the complement system, thereby
releasing chemotactic complement fragments [10,11]. Moreover,
recent in vitro studies suggest that the PA system appears to be
involved in the intracellular signaling events during inflammation.
For instance, plasmin can activate the p38 mitogen-activated
protein kinase (MAPK), Janus kinase (JAK), signal transducers and
activators of transcription (STAT) signaling pathways in mono-
cytes, which have been shown to be important for the
inflammatory response [12]. Plasmin is also known to stimulate
the release of cytokines and other inflammatory mediators by
different cell types [13]. During severe infection, uncontrolled
release of cytokines such as tumor necrosis factor-alpha (TNF-a)
and interleukin-6 (IL-6) may cause a so-called cytokine storm [14].
An uncontrolled cytokine storm leads to sepsis, and is therefore
fatal. However, although various mechanisms underlying the
inflammatory response during infection have been proposed, the
possible functional roles of the PA system during infection, and
during sepsis especially, remain largely unknown.
I nt h ec u r r e n ts t u d y ,w eh a v eu s e ds i n g l eg e n e - d e f i c i e n tm i c e
lacking plasminogen (plg
-/-), uPA (uPA
-/-), tPA (tPA
-/-), and doubly
deficient mice lacking both tPA and uPA (tPA
-/-/uPA
-/-), to study the
functional roles of plasmin during S. aureus-induced infection and
sepsis. Our data show that the plasmin shows contrasting roles in
infection and sepsis.
Results
Reduced survival rate upon induction of infection and
increased survival rate upon induction of sepsis in plg
-/-
mice in comparison to WT mice
To reveal the functional roles of plasmin in infection and sepsis,
we used WT, plg
+/-, and plg
-/- mice, which exhibit 100%, 50%,
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Infection and sepsis were achieved by intravenous injection of
1610
7 or 1.6610
8 CFU of S. aureus, respectively, and the survival
of mice was thereafter followed for 25 days. As shown in Figure 1A,
in the first 4 days after bacterial injection no mice died in the
infection group. From day 5 to day 25, the survival rates of WT,
plg
+/-, and plg
-/- mice were 86.7%, 80%, and 50%, respectively.
The survival rate in plg
-/- mice upon induction of infection was
significantly lower (P=0.04) than that in the WT mice. A
contrasting result was obtained when sepsis was induced
(Figure. 1B and Table 1). In this model, the median survival time
in plg
-/- mice was 156 h, which was significantly longer (P=0.009)
than that in WT mice (40 h). Interestingly, the median survival
time and the survival curve of plg
+/- mice were intermediate as
compared to WT and plg
-/- mice. These data show that
plasminogen deficiency has contrasting effects on the survival
Figure 1. Survival curves of mice with different genotypes during infection and sepsis. A. Mice were inoculated with 1610
7 CFU of
S. aureus to induce infection. Survival of WT (n=15), plg
-/- (n=16) and plg
+/- (n=15) mice was followed for 25 days. Significant differences were found
between WT and plg
-/- mice (log-rank test, P,0.05). B. Mice were inoculated with 1.6610
8 CFU of S. aureus to induce sepsis. Survival of WT (n=28),
tPA
+/-/uPA
+/- (n=10), tPA
-/- (n=13), uPA
-/- (n=15), plg
+/- (n=20), plg
-/- (n=10), and tPA
-/-/uPA
-/- (n=7) mice was followed for 8 days. Significant
differences were found between WT mice and plg
-/- mice (log-rank test, P,0.01).
doi:10.1371/journal.pone.0024774.g001
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levels of plasminogen affect the survival phenotype.
PA-deficient mice have delayed onset of death and an
improved survival
Plasminogen is converted to the active enzyme plasmin by
either uPA or tPA. We therefore studied S. aureus-induced
sepsis in tPA
-/- or uPA
-/- mice, and also in doubly deficient
(tPA
-/-/uPA
-/-) mice. As shown in Figure 1B and Table 1, the
tPA
-/- and uPA
-/- mice showed delayed onset of death and
significantly elevated survival rates as compared to WT mice (log-
rank test P=0.04). Moreover, when tPA
-/-/uPA
-/- mice were
used to induce sepsis, they showed the longest median survival
time compared to all other genotypes. The delayed onset of death
in these tPA
-/-/uPA
-/- mice was even more evident than in plg
-/-
mice (Figure 1B and Table 1). These data suggest that lack of tPA
and/or uPA in mice significantly enhances the survival rate, and
prolongs the onset of death in S. aureus-induced sepsis, thus
confirming the notion that active plasmin plays a key role in the
mortality of sepsis.
Comparison of viable bacterial counts in mouse organs
after induction of infection and sepsis
In order to study whether there was a difference in the presence
of bacteria in different organs in WT and plg
-/- mice after
induction of infection, both genotypes of mice were inoculated
with 1610
7 CFU of S. aureus, and 24 h later numbers of viable
bacteria were counted from various organs. As shown in Figure 2A,
the bacterial counts in liver, kidney, spleen, and blood were similar
in WT and plg
-/- mice. The bacterial counts in brain, however,
were significantly higher in WT mice than in plg
-/- mice. These
results suggest that in the blood and in most organs, the ability to
kill bacteria was similar in WT and plg
-/- mice at this early stage of
infection. The difference in bacterial counts in the brain suggests
that plasminogen may be required for bacterial invasion through
the blood-brain barrier (BBB) [15,16].
We also investigated the presence of viable bacteria in various
organs after induction of sepsis in WT, tPA
-/-, uPA
-/-,
tPA
-/-/uPA
-/-, and plg
-/- mice. As shown in Figure 2B, the
numbers of viable bacteria in the blood were not significantly
different in all genotypes studied at 24 h after bacterial injection.
However, as shown in Figure 2C–2F, the viable bacterial counts in
the spleen, brain, liver, and kidney of WT, tPA
-/-, and uPA
-/- mice
were significantly higher than those in tPA
-/-/uPA
-/- mice and
plg
-/- mice. The viable bacterial counts in all organs studied were
not significantly different in WT, tPA
-/-, and uPA
-/- mice. The
bacterial counts in the brains of tPA
-/-/uPA
-/- mice were
significantly higher than those in plg
-/- mice, but this was not
the case for other organs (Figure 2D). These data suggest that in
sepsis, the bacterial killing ability is improved in mice with reduced
levels of functional plasmin. Taken together, our data show that
plasmin exhibits contrasting functions in bacterial killing in
infection and sepsis.
Higher serum levels of TNF-a, IL-6, and IL-10 in WT mice
than in plg
-/- mice during sepsis
In vitro studies have indicated that plasmin stimulates the
expressions of several cytokines [13]. A dramatic increase in
inflammatory cytokine levels is one of the major clinical features of
sepsis [17,18]. To study how plasminogen affects the cytokine
production, we studied the profiles of inflammatory cytokines in
the sera of WT and plg
-/- mice during infection and sepsis. As
shown in Figure 3A (sepsis) and 3B (infection), serum levels of
TNF-a reached a maximum level at 2 h after the injection of S.
aureus, and gradually fell thereafter in both genotypes of mice and
in both infection and sepsis. After induction of sepsis (Figure 3A),
significantly higher TNF-a levels were seen in WT mice than in
plg
-/- mice at all 4 time points studied. In contrast, in the infection
model (Figure 3B), the TNF-a levels were either comparable (at
6 h and 24 h) or significantly lower (at 2 h and 36 h) in WT mice
than in plg
-/- mice.
As shown in Figure 3C and 3D, IL-6 levels were comparable in
WT mice and plg
-/- mice at 6 h, for both the infection model and
the sepsis model. However, 24 h after induction of sepsis, WT
mice had 8-fold higher levels of IL-6 than plg
-/- mice (Figure 3C),
while no difference was observed at the same time point in the
infection model (Figure 3D). At 24 h after induction of sepsis, the
IL-6 levels in the sera of plg
+/- mice were also significantly lower
than those in WT mice, but significantly higher than those in plg
-/-
and tPA
-/-/uPA
-/- mice (Figure 3E).
As shown in Figure 3F, at 24 h after induction of sepsis, the IL-
10 levels were significantly higher in WT mice than in plg
-/- mice,
while the levels of IL-10 were similar between the two genotypes in
the infection model. Furthermore, in both genotypes of mice, IL-
10 levels were significantly higher in sepsis than in infection.
Taken together, these data demonstrate that during sepsis, plg
-/-
mice have significantly lower cytokine levels than WT mice.
In addition, during sepsis, since the IL-6 levels are highest in
WT mice, intermediate in plg
+/- mice, and lowest in both
tPA
-/-/uPA
-/- and plg
-/- mice, the increase in cytokine levels
appears to be related not only to levels of plasminogen but also to
levels of active plasmin.
Table 1. Median survival time and mean onset time of death after induction of sepsis in different genotypes of mice.
Genotypes Number of mice used Median survival time (h) Mean onset time of death (h)
{
WT 28 40
* 64.068.8
tPA
+/-/uPA
+/- 10 40 54.7610.7
tPA
-/- 13 132 88.5615.9
uPA
-/- 15 132 86.8614.0
plg
+/- 20 126 70.3613.7
plg
-/- 10 156 122.0614.0
tPA
-/-/uPA
-/- 7 168 141.069.0
{Data presented as Mean 6 SD.
,* P,0.05. WT group was compared with plg
-/- group.
doi:10.1371/journal.pone.0024774.t001
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antibodies
IL-6 is an important pro-inflammatory cytokine that is
upregulated during sepsis [19]. As we found that the serum levels
ofIL-6 were significantlyhigherinWTmicethaninplg
-/-mice 24h
after induction of sepsis, we tested the hypothesis that neutralization
of IL-6 may delay the onset of death, or improve the survival rate in
oursepsismodel.Asshown inFigure 4 and Table 2, when WT mice
were treated with an anti-IL-6 neutralizing antibody (1.33 mg per
kg body weight) at 1 h before and 24 h after the induction of sepsis,
the onset of death was delayed for a period of 45 h, and the survival
rate was significantly elevated as compared to mice treated with
control IgG (P,0.05). WT mice treated with anti-IL-6 antibody
showed a similar survival curve to that of plg
-/- mice, which suggests
that lack of plasminogen improves the chances of survival from
sepsis by reducing the production of IL-6.
Figure 2. Bacterial counts in different organs and in different genotypes of mice. A. Bacterial counts in brain, liver, kidney, spleen, and
blood of WT and plg
-/- mice 24 h after inoculation with 1610
7 CFU of S. aureus. B.–F. Bacterial counts in blood, spleen, brain, liver, and kidney 24 h
after inoculation of 1.6610
8 CFU of S. aureus to different genotypes of mice. The means 6 SD of 8 mice are shown. NS=not significant, *=P,0.05
was considered significant, by One-way ANOVA, with Bonferroni’s Multiple Comparison test.
doi:10.1371/journal.pone.0024774.g002
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STAT3 is a key molecule in mediating signaling of several
inflammatory cytokines during an acute inflammatory response
[20]. To study if plasminogen deficiency affect STAT3 activation,
we measured the levels of phosphorylated and total STAT3 in
spleen neutrophils obtained 24 h after infection and sepsis
induction (Figure 5A and 5B). In the infection model, levels of
STAT3 and phosphorylated STAT3 are either moderately
increased (in WT mice) or remained unchanged (in plg
-/- mice)
as compared to uninfected controls. In the sepsis model, levels of
total and phosphorylated STAT3 in WT mice increased
significantly upon induction of sepsis. However, the levels
remained largely unchanged in plg
-/- mice under sepsis challenge,
indicating that plasmin is involved in the activation of the STAT3
signaling pathway in sepsis, which may contribute to the
differences in cytokine levels, bacterial killing ability, and mortality
between WT and plg
-/- mice during infection and sepsis.
Comparison of intensity of C5a on blood neutrophils in
WT and plg
-/- mice during sepsis
Studies using a murine cecal ligation and puncture sepsis model
have shown that exposure of neutrophils to C5a at concentrations
Figure 3. Serum levels of TNF-a, IL-6, and IL-10 during infection and sepsis. Blood samples were taken at the indicated time points.
A. TNF-a ´ levels in sera from WT and plg
-/- mice after induction of sepsis. B. TNF-a ´ levels in sera from WT and plg
-/- mice after induction of infection.
C. IL-6 levels in sera from WT and plg
-/- mice after induction of sepsis. D. IL-6 levels in sera from WT and plg
-/- mice after induction of infection. E. IL-6
levels in sera from WT, plg
+/-, tPA
-/-/uPA
-/-, and plg
-/- mice after induction of sepsis. F. IL-10 levels in sera from WT and plg
-/- mice after induction of
infection or sepsis. The means 6 SD of 5 mice are shown. NS=not significant, *=P,0.05 was considered significant, and **=P,0.01 was considered
extremely significant, by 2-tailed t-test.
doi:10.1371/journal.pone.0024774.g003
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dysfunction and paralysis of signaling pathways [21]. We therefore
investigated whether plasminogen deficiency may influence the
surface deposition of C5a on blood neutrophils after induction of
sepsis. Twenty-four and 36 h after induction of sepsis, the intensity
of C5a on neutrophils was determined. As shown in Figure 6, the
intensity of C5a on neutrophils was lower in plg
-/- mice than in
WT mice at 24 h after sepsis induction and was further reduced at
36 h. The diminished deposition of C5a on neutrophils in plg
-/-
mice during sepsis suggests that C5a may contribute to the
underlying molecular mechanisms in our sepsis model.
Discussion
In the present study, we report that plasmin plays a beneficial
role in S. aureus-induced infection, but a detrimental role in S.
aureus-induced sepsis. Several pro- and anti-inflammatory cyto-
kines showed different profiles in WT and plg
-/- mice during
infection and sepsis. In sepsis, blockade of IL-6 improved the
survival of WT mice to a level that is close to plg
-/- mice.
Furthermore, deposition of the active complement mediator C5a
on the surface of neutrophils as well as activation of STAT3 is
impaired in plg
-/- mice after induction of sepsis. These data
demonstrate that plasmin has important functions in sepsis, which
may go beyond its classical roles of degrading fibrin and
extracellular matrix. In recent years, in vitro studies have suggested
that plasmin plays a role in regulating signaling pathways, and in
stimulating the release of cytokines and other inflammatory
mediators [13]. To our knowledge, this is the first study that
targets the roles of plasmin during host responses to infection and
sepsis with in vivo models. Our results indicate that plasmin plays
important roles in regulating cytokine expression, inflammatory
signal transduction, bacterial killing ability, and mice survival rate
during infection and sepsis.
We have previously shown that plasminogen levels are
important for the incidence and severity of collagen II-induced
arthritis [22]. Similarly, in the current study, our data with the
sepsis model showed three types of survival phenotypes: (1)
tPA
-/-/uPA
-/- and plg
-/- mice, which cannot form active plasmin,
have the highest survival rate, the longest median survival time,
and the latest time of onset of death; (2) WT and tPA
+/-/uPA
+/-
mice have the lowest survival rate, the shortest median survival
time, and the earliest time of onset of death; and (3) plg
+/-, uPA
-/-,
and tPA
-/- mice have intermediate survival rate and time of onset
of death. Because both tPA and uPA can activate plasminogen to
functional plasmin, tPA or uPA singly deficient mice still have the
capacity to convert plasminogen to active plasmin. Furthermore,
tPA
-/-/uPA
-/- mice have normal levels of plasminogen, but they
cannot activate plasminogen to active plasmin. Thus, the survival
data from the sepsis study suggest that it is the relative plasmin
levels that determine the survival outcomes during sepsis.
During infection, however, WT and plg
+/- mice showed similar
survival rates. These data indicate that unlike in sepsis, the average
time of onset of death in the infection model was less dependent on
the level of plasminogen. Furthermore, in sepsis, mice with normal
or apparently normal ability to form plasmin (WT, tPA
-/-, and
uPA
-/- mice) all had significantly impaired bacterial killing ability
as compared to mice that are unable to form plasmin
(tPA
-/-/uPA
-/- or plg
-/- mice). Moreover, the IL-6 levels in plg
+/-
mice were approximately half of those in WT mice at 24 h after
induction of sepsis, indicating that the relative levels of
plasminogen also affect cytokine production. Based on these
results, we propose that the available level of plasmin is critical for
the onset of death, bacterial killing ability, and cytokine production
in the development of sepsis.
STAT3 is a key molecule in mediating the signaling of many
inflammatory cytokines such as TNF-a, IL-6, and IL-10 during
inflammatory responses. TNF-a and IL-6 have been considered to
be the primary mediators of sepsis [23], and a positive correlation
has been found between serum IL-6 and TNF-a levels and
multiple organ failure [24,25]. IL-10 has a pronounced anti-
inflammatory effect by reducing the level of superoxide production
in neutrophils, which interferes with neutrophil-mediated cellular
cytotoxicity [26]. Previous in vitro studies have shown that plasmin
stimulates the expression of cytokines in human monocytes [13].
Figure 4. Blockade of IL-6 in WT mice during sepsis. Comparison
of survival curves between anti-IL-6 antibody-treated mice (n=9) and
control IgG-treated mice (n=14). The anti-IL-6 antibody-treated mice
showed significantly improved survival as compared to control
IgG-treated mice (log-rank test, P,0.05).
doi:10.1371/journal.pone.0024774.g004
Table 2. Median survival time and mean onset time of death with or without treatment of anti-IL-6 antibody (Ab) during sepsis.
Mouse group Number of mice used Median survival time (h) Mean onset time of death (h)
{
WT with control IgG 14 52
* 64612.4
WT with anti-IL-6 Ab 9 160 100.8619.5
plg
-/- with PBS 10 156 120.0613.5
{Data presented as Mean 6 SD.
*, P,0.05. Anti-IL-6 Ab-treated group was compared to control IgG-treated group.
doi:10.1371/journal.pone.0024774.t002
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STAT3 remained largely unchanged in plg
-/- mice undergoing
sepsis, which is in contrast to the dramatic increased STAT3
activation in WT mice undergoing sepsis. In addition, we also
found that TNF-a, IL-6, and IL-10 levels were significantly lower
in plg
-/- mice than in WT mice during sepsis. In tPA
-/-/uPA
-/-
mice, the IL-6 was at a low level similar to that in plg
-/- mice. It is
well known that the cytokine storm during sepsis induces an
overwhelming inflammatory response, which leads to multiple
organ failure and subsequent death. Blocking cytokines such as
TNF- a, IL-6 and IL-1 did show benefit in patients with
bacteremia [27]. Diminished cytokines levels in plg
-/- and
tPA
-/-/uPA
-/- mice indicate that there is a strong correlation
between levels of active plasmin, cytokine expression and STAT3
activation. The data presented here suggest that reducing or
removing functional plasmin in mice, leads to a higher survival
rate during sepsis due to an impaired cytokine production. Studies
of how plasmin regulate cytokine expression and downstream
signal pathways during sepsis are being carried out in our
laboratory.
Several studies have shown that mice with low complement
activity have impaired host defense during infection [28–30],
whereas during sepsis excessive complement activation leads to
compromised innate immune functions [31]. Blockade of C5a or
the C5areceptor withantibodies has been shown to greatly improve
survival of rodents during sepsis [32,33]. In the current study, the
contrasting phenotypes in terms of survival rate and cytokine
expression between plg
-/- and WT mice during infection and sepsis
are in accordance with the results of previous studies in mice with
dysfunction of the complement system [34]. We have also shown
that both the phosphorylated and total protein expression levels of
STAT3 in spleen neutrophils of plg
-/- mice were markedly lower
than those in WT mice after induction of sepsis. Thus, one possible
explanation is that plasmin is important in mediating complement
activation, which subsequently activates the STAT3 signaling
pathway and contributes to the different phenotypes observed in
plg
-/- and WT mice during infection and sepsis.
In summary, the current study reveals a contrasting role of
plasminogen deficiency in infection and sepsis, and suggests that
pro-inflammatory plasmin plays deleterious roles during system-
ic inflammation (sepsis). This pro-inflammatory function of
plasmin is distinctly different from its classical roles as a
protease that degrades fibrin and extracellular matrix. Our
findings may be potentially useful for the development of novel
therapeutic strategies against infection and sepsis in humans.
Materials and Methods
Experimental animals
Plasminogen-heterozygous (plg
+/-) mice [35] of mixed genetic
background (1296C57BL/6) were intercrossed to generate wild-
type (WT), plg
+/- and plasminogen-deficient (plg
-/-) mice. tPA-
deficient (tPA
-/-) and uPA-deficient (uPA
-/-) mice [36] were
backcrossed 10 times to mice of C57BL/6 genetic background.
The tPA/uPA doubly deficient (tPA
-/-/uPA
-/-) mice were
generated by crossing tPA
-/- mice with uPA
-/- mice. The mice
were genotyped by PCR and by measuring plasma levels of
Figure 5. Western blot analysis of the expression levels of STAT3 in spleen neutrophils. Neutrophils from uninfected control, infection,
and sepsis mice are as described in Materials and Methods. Lanes 1, 3, and 5: neutrophil lysates from WT mice; lanes 2, 4, and 6: neutrophil lysates
from plg
-/- mice. A. Levels of total STAT3 in neutrophil lysates. B. Levels of phosphorylated STAT3 in neutrophil lysates. C. Levels of b-actin in the
lysates, corresponding to each lane in A and B as internal controls. Experiments were repeated at least 3 times and representative results are shown.
doi:10.1371/journal.pone.0024774.g005
Figure 6. Intensity of C5a deposition on blood neutrophils in
sepsis. Mice were inoculated with 1.6610
8 CFU of S. aureus to induce
sepsis. Twenty-four hours and 36 h after inoculation, blood neutrophil
samples were taken and stained with anti-C5a IgG. The deposition
intensity is presented by mean fluorescence intensity (MFI). The means
6 SD of 4 mice are shown. *=P,0.05 was considered significant, by
2-tailed t-test.
doi:10.1371/journal.pone.0024774.g006
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of age, with a body weight 22 grams or more were used for the
experiments. In control experiments, the survival rates during
infection and sepsis were also determined in female mice.
However, no gender-related differences were found (Data not
shown).The regional ethical committee of Umea ˚ University
approved all experimental protocols (Approval ID: A118-05).
Bacterial strains
The Phillips strain of S. aureus isolated from a patient with
osteomyelitis was kindly supplied by Dr. Ho ¨o ¨k, Gothenburg,
Sweden. S. aureus was grown either in LB broth or on LB agar
plates.
Models for induction of infection and sepsis
Infection model. Mice were challenged by intravenous
injection with 1610
7 CFU of S. aureus Phillips. The survival rate
was examined over the whole experiment (up to 25 days).
Sepsis model. Mice were challenged by intravenous
injection with 1.6610
8 CFU of S. aureus Phillips. The survival
rate was examined over the whole experiment (up to 8 days).
Bacterial counts in blood and different organs
Twenty-four hours after injection of the bacteria in amounts
compatible with either infection or sepsis, the mice were killed and the
blood, brain, spleen, liver, and kidney were collected and homogenized
in 2 ml sterile PBS. After serial dilution, the homogenates and the
blood were spread on LB agar plates and incubated at 37uC for 24 h.
Colonies were counted and expressed as CFU/organ.
ELISA
At the indicated time points after induction of infection or sepsis,
approximately 600 ml blood were collected, placed on ice and
allowed to clot before centrifugation at 30006g for 10 min. Serum
samples were then used for ELISA. The serum levels of TNF-a, IL-
6, and IL-10 were measured using ELISA kits according to the
instructions of the manufacturer (Nordic Biosite, Ta ¨by, Sweden).
Western blot analysis
Twenty-four hours after induction of infection or sepsis, spleens
were collected and homogenized on ice, and the neutrophils were
isolated by Percoll gradients (P4937; Sigma-Aldrich, Stockholm,
Sweden). Neutrophils were lysed with 1% NP-40 and protease
inhibitor cocktail. Thereafter, protein concentrations were mea-
sured by the BCA protein assay method (Pierce Biotechnology,
Rockford, IL). Thirty micrograms of protein was electrophoresed
by SDS-PAGE (7.5%), and transferred to polyvinylidene difluoride
membranes (Amersham, UK) for western blot. Anti-STAT3 and
anti-phosphorylated-STAT3 (Tyr
705) antibodies were obtained
from Cell Signaling Technology (Boston, MA). The mouse
monoclonal antibodies to b-actin were purchased from Sigma-
Aldrich, Sweden. Western blot analyses were carried out as
described by Persau et al [38].
Detection of C5a on blood neutrophils during sepsis by
flow cytometry
Flow cytometric staining was performed on whole blood from 5
WT mice and 5 plg
-/- mice at 24 and 36 h, respectively, after
sepsis induction. Leukoctes isolation was essentially followed by
Zhang et al [39]. Cells were incubated with rat antibody to mouse
neutrophils (MCA771G; Serotec, UK) and goat antibody to
mouse C5a (AF2150; Minneapolis, MN) for 30 min on ice. After
washing the secondary antibodies with FACS buffer, FITC-
labeled sheep anti-rat IgG diluted 1:100 (AAR10F; Serotec, UK)
or PE-labeled donkey anti-goat IgG diluted 1:200 (Rockland
Immunochemicals, PA) was added. The cells were washed once
with FACS buffer and resuspended in 500 ml PBS. The samples
were analyzed by double-colour fluorescence flow cytometry with
cytomics FC500 (Beckman Coulter) for the detection of C5a
intensity on blood neutrophils.
IL-6 blockade in WT mice 1 h prior to and 24 h after
bacterial challenge
A rat monoclonal antibody (anti-IL-6; BD PharMingen, San
Diego, CA) that specifically neutralize recombinant mouse IL-6 were
used. The antibody were given to 9 WT mice at a dose of 1.33 mg
per kg body weight at 1 h prior to and 24 h after the induction of
sepsis. As controls, 14 WT mice were given control IgG (R3-34; BD
PharMingen, San Diego, CA) at the same dosage. The mice were
monitored every 8 h, and were killed 192 h after induction of sepsis.
Statistical analysis
Results of bacterial counts are expressed as the mean 6 SD.
Data sets were analyzed using One-way ANOVA, with Bonferro-
ni’s Multiple Comparison test. Results of cytokine levels are
expressed as the mean 6 SD. Data sets were analyzed using 2-
tailed t-test. To compare the survival curves among different
genotypes of mice, log-rank test was used. P values less than 0.05
were considered significant.
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